Power-Chip Maker Wolfspeed's Stock Falls Despite Earnings Beat -- Barrons.com
Dow Jones2026/08/19 20:27By Anita Hamilton
Shares of Wolfspeed, which makes silicon carbide wafers and power chips, fell in after-hours trading despite beating analyst expectations on earnings.
While its fourth-quarter revenue of $150 million was in line with analyst expectations, its loss of $2.26 a share beat the expected $2.45 a share loss.
Shares fell 7% to $27 after closing down 7.5% in regular trading.
The company said AI data center sales increased by 20% in the fourth quarter, compared with the prior quarter, and doubled for the full fiscal year.
The Durham, N.C.-based company has two main businesses: sales of silicone carbide wafers in its materials division, and power chips and modules in its power products segment. While sales to the electric car industry in both divisions have declined amid lower demand for those vehicles, demand for its power products has increased from artificial-intelligence data centers in recent quarters.
The company emerged from Chapter 11 last September, and its shares are up 67% in 2026.
This is breaking news. Check back for updates.
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 19, 2026 16:27 ET (20:27 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Zcash co-founder releases ZIP proposal to "terminate ZCG funding channel and instead support NSM"
Citadel warns: Tech stock sell-off is just the first warning sign, AI trading offers "almost no room for error"
The sell-off in tech stocks reflects rising doubts about AI profitability, with Citadel stating that there is very little margin for error in AI trading. Grayscale noted that demand is parabolic, and capital expenditure presents a two-sided risk.
Daiwa raises Tesla's target price to $390
U.S. judge rejects injunction, Novo Nordisk (NVO.US) loses first round in blocking Eli Lilly (LLY.US) weight-loss drug advertisements
On Monday, a U.S. judge dismissed Novo Nordisk's request to prohibit Eli Lilly from continuing to run advertisements for weight-loss drugs. The Danish pharmaceutical company argued that the ads were false and misleading, in a market with annual sales worth tens of billions of dollars.
Crypto prices
More
